However, it's important to set realistic expectations
The KPV literature, particularly the Dalmasso and Kannengiesser work, is solid for a peptide at this stage
If they disagree, figure out why before proceeding
By incorporating a broader range of patient-relevant outcomes, clinical trials can provide a more comprehensive understanding of the impact of disease-modifying therapies on the overall well-being of individuals with PD
A source-checked guide to peptide oxidation, including vulnerable residues, environmental accelerators, and what oxidation evidence does and does not prove
Share logs with your clinician or dietitian to speed effective tweaks